Skip to main content

Independent effect of fatigue on health-related quality of life in patients with idiopathic Parkinson’s disease


Nonmotor symptoms (NMS) of idiopathic Parkinson’s disease (IPD), specifically fatigue, depression and sleep disturbances, are important contributors for worse quality of life and poor patient outcomes. The aim of this research is to determine the relationship between fatigue and other NMS and the independent effect of fatigue on health-related quality of life (HRQoL) in patients with IPD. 86 IPD patients and 85 healthy individuals were included in our study. Participants were evaluated by their answers to the Beck Depression Inventory, Fatigue Severity Scale, Epworth Sleepiness Scale and Parkinson’s Disease Questionnaire-39. Hoehn–Yahr stage, disease duration, medications and demographical characteristics were also noted. ROC analysis was used to determine the cutoff point for HRQoL. Nonparametric Spearman correlation analysis was used for determining the relationship between variables. Independent factors which affect HRQoL were detected by multiple forward stepwise logistic regression analysis. NMS were associated with each other and with HRQoL when they act concomitantly (p < 0.001). Of these three frequent NMS, depression (p < 0.05) and fatigue (p < 0.001) had independent worsening effect on HRQoL, whereas sleep disturbances did not (p > 0.05). The stage of IPD and levodopa–entacapone treatment had independent effects on HRQoL too (p < 0.05). Fatigue was found as the most important factor which affects HRQoL among all investigated NMS. So, it is important to ask about fatigue in routine controls of IPD patients and try to treat it for improving life quality.

This is a preview of subscription content, access via your institution.


  1. George S, Rey NL, Reichenbach N, Steiner JA, Brundin P (2013) α-Synuclein: the long distance runner. Brain Pathol 3(3):350–357

    Article  Google Scholar 

  2. Opara JA, Brola W, Leonardi M, Blaszczyck B (2012) Quality of life in Parkinson’s disease. J Med Life 5(4):375–381

    PubMed Central  CAS  PubMed  Google Scholar 

  3. Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG (2014) Relationship between the MDS-UPDRS domains and the health related quality of life of Parkinson’s disease patients. Eur J Neurol 21(3):519–524

    CAS  Article  PubMed  Google Scholar 

  4. Romani A (2008) The treatment of fatigue. Neurol Sci 29(2):247–249

    Article  Google Scholar 

  5. Greim B, Benecke R, Zettl UK (2007) Qualitative and quantitative assessment of fatigue in multiple sclerosis (MS). J Neurol 254(2):II58–II64

    PubMed  Google Scholar 

  6. Pfeiffer RF (2007) Non-motor parkinsonism. Parkinsonism Relat Disord 13(3):211–220

    Article  Google Scholar 

  7. Mendonça DA, Menezes K, Jog MS (2007) Methylphenidate improves fatigue scores in Parkinson’s disease: a randomized controlled trial. Mov Disord 22(14):2070–2076

    Article  PubMed  Google Scholar 

  8. Datieva VK, Rosinskaia AV, Levin OS (2013) The use of melatonin in the treatment of chronic fatigue syndrome and circadian rhythm disorders in Parkinson’s disease. Zh Nevrol Psikhiatr Im S S Korsakova 113(7 Pt 2):77–81

    CAS  PubMed  Google Scholar 

  9. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46(10):1121–1123

    CAS  Article  PubMed  Google Scholar 

  10. Izci B, Ardic S, Fırat H, Sahin A, Altınors M, Karacak I (2008) Reliability and validity studies of the Turkish version of the Epworth Sleepiness Scale. Sleep Breath 12:161–168

    Article  PubMed  Google Scholar 

  11. Beck Aaron T (1998) Psychometric properties of the Beck Depression Inventory: twenty five years of evaluation. Clin Psychol Rev 8(1):77–100

    Article  Google Scholar 

  12. The Global Parkinson’s Disease Survey (GPDS) Steering Committee (2002) Factors impacting on quality of life in Parkinson’s disease: results from an international survey. Mov Disord 17(1):60–67

    Article  Google Scholar 

  13. Peto V, Jenkinson C, Fitzpatrick R et al (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res 4:241–248

    CAS  Article  PubMed  Google Scholar 

  14. Shulman LM, Taback RL, Bean J, Weiner WJ (2001) Comorbidity of the nonmotor symptoms of Parkinson’s disease. Mov Disord 16(3):507–510

    CAS  Article  PubMed  Google Scholar 

  15. Okuma Y, Kamei S, Morita A, Yoshii F, Yamamoto T, Hashimoto S, Utsumi H, Hatano T, Hattori N, Matsumura M, Takahashi K, Nogawa S, Watanabe Y, Miyamoto M, Hirata K (2009) Fatigue in Japanese patients with Parkinson’s disease: a study using Parkinson fatigue scale. Mov Disord 24(13):1977–1983

    Article  PubMed  Google Scholar 

  16. Kang SY, Ma HI, Lim YM, Hwang SH, Kim YJ (2013) Fatigue in drug-naive Parkinson’s disease. Eur Neurol 70(1–2):59–64

    Article  PubMed  Google Scholar 

  17. Friedman JH, Friedman H (1993) Fatigue in Parkinson’s disease. Neurology 43:2016–2018

    CAS  Article  PubMed  Google Scholar 

  18. Stocchi F, Abbruzzese G, Ceravolo R, Cortelli P, D’Amelio M, De Pandis MF, Fabbrini G, Pacchetti C, Pezzoli G, Tessitore A, Canesi M, Iannacone C, Zappia M, FORTE Study Group (2014) Prevalence of fatigue in Parkinson’s disease and it’s clinical correlates. Neurology 83(3):215–220

    Article  PubMed  Google Scholar 

  19. Oved D, Ziv I, Treves TA, Paleacu D, Melamed E, Djaldetti R (2006) Effect of dopamine agonists on fatigue and somnolence in Parkinson’s disease. Mov Disord 21(8):1257–1261

    Article  PubMed  Google Scholar 

  20. Karlsen K, Larsen JP, Tandberg E, Jorgessen K (1999) Fatigue in patients with Parkinson’s disease. Mov Disord 14(2):237–241

    CAS  Article  PubMed  Google Scholar 

  21. Alves G, Wentzel-Larsen T, Larsen JP (2004) Is fatigue an independent and persistant symptom in patients with Parkinson’s disease? Neurology 63(10):1908–1911

    CAS  Article  PubMed  Google Scholar 

  22. Lou JS, Dimitrova DM, Park BS, Johnson SC, Eaton R, Arnold G, Nutt JG (2009) Using modafinil to treat fatigue in Parkinson’s disease: a double blind, placebo-controlled pilot study. Clin Neuropharmacol 32(6):305–310

    CAS  Article  PubMed  Google Scholar 

  23. Elbers RG, van Wegen EE, Verhoef J, Kwakkel G (2014) Impact of fatigue on health-related quality of life in patients with Parkinson’s disease: a prospective study. Clin Rehabil. 28(3):300–311

    Article  PubMed  Google Scholar 

  24. Song W, Guo X, Chen K, Chen X, Cao B, Wei Q, Huang R, Zhao B, Wu Y, Shang HF (2014) The impact of nonmotor symptoms on the health related quality of life of Parkinson’s disease patients from Southwest China. Parkinsonism Relat Disord 20(2):149–152

    Article  PubMed  Google Scholar 

  25. Mao CJ, Cao LD, Tang Q, Liu CF (2013) Observations on fatigue, depression and quality of life in patients with Parkinson’s disease. Zhonghua Nei Za Zhi 52(3):200–202

    Google Scholar 

Download references


No funding source was used during the research. No other people than researchers participated in this study.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Vasfiye Burcu Dogan.

Ethics declarations

Conflict of interest

We have no potential conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Dogan, V.B., Koksal, A., Dirican, A. et al. Independent effect of fatigue on health-related quality of life in patients with idiopathic Parkinson’s disease. Neurol Sci 36, 2221–2226 (2015).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • Idiopathic Parkinson’s disease
  • Nonmotor symptoms
  • Fatigue
  • Fatigue Severity Scale
  • PDQ-39
  • Health-related quality of life